Benzodiazepines and Other Targeted Substances Regulations (SOR/2000-217)
Full Document:
Regulations are current to 2013-04-29 and last amended on 2012-11-21. Previous Versions
General Obligations of Pharmacists
Marginal note:Change of location
56. A pharmacist who closes premises in which a targeted substance has been stored must, not later than 10 days after the closure, inform the Minister of the date of closure, the location to which the targeted substance was moved and the quantity of the targeted substance that was moved.
Marginal note:Renunciation of privileges
57. (1) A pharmacist who does not wish to receive or have possession of targeted substances may make a written request to the Minister to send to licensed dealers and pharmacies a notice, issued under section 79, that states that targeted substances must not be supplied to that pharmacist.
Marginal note:Prohibited actions
(2) A pharmacist must not, unless their pharmacy has received a retraction issued under section 80,
(a) sell or provide a targeted substance to a pharmacist or practitioner named in a notice issued under section 79; or
(b) fill a prescription or order for a targeted substance from a practitioner named in a notice issued under section 79.
PART 3
PRACTITIONERS
Marginal note:To patients only
58. A practitioner may, with respect to a targeted substance, prescribe it for or administer it to an individual or animal, or sell, provide, send, deliver or transport it to or for an individual or for the benefit of an animal, only if
(a) the individual or animal is a patient that the practitioner is treating in their professional capacity; and
(b) the targeted substance is required to treat the individual’s or animal’s medical condition.
- SOR/2010-223, s. 26(F).
Marginal note:Emergency supply
59. (1) A practitioner of medicine may store an emergency supply of targeted substances at a remote location where emergency medical treatment is not readily available or in an emergency medical service vehicle, if the practitioner has an agent at that location or in the vehicle who will control and administer the targeted substances on behalf of, and under the direction of, the practitioner.
Marginal note:Emergency use
(2) When aid is being provided to an individual in an emergency, the agent of the practitioner of medicine may administer a targeted substance from the emergency supply to the individual if
(a) the practitioner of medicine has, by telephone or other means, directed the agent to administer the targeted substance; or
(b) the agent follows written directives provided by the practitioner with respect to the administration of the targeted substance.
- SOR/2010-223, s. 27.
Marginal note:Records — practitioner
60. (1) A practitioner must keep the following records:
(a) the brand name or, if the targeted substance does not have a brand name, the specified name, the quantity and strength per unit of any targeted substance received from a licensed dealer, pharmacist or hospital and the date on which it is received;
(b) the name and address of the licensed dealer, pharmacist or hospital that sold or provided the targeted substance;
(c) if a transaction involves a quantity of targeted substance that exceeds five times the usual daily dose for the substance, the name and quantity of the substance prescribed, administered, sold, provided, sent, delivered or transported, the name and address of the recipient and the date of the transaction; and
(d) in the case of an emergency supply referred to in subsection 59(1), the name of the administering agent, the location of the emergency supply, the name, quantity and strength per unit of each targeted substance, the date of all transactions related to that emergency supply and the name of any individual to whom the targeted substance was administered.
Marginal note:Records — agent
(2) In respect of the administration of a targeted substance from an emergency supply referred to in subsection 59(1), the agent of the practitioner must keep the following records:
(a) the name, strength per unit and quantity of each targeted substance administered and the date on which it was administered;
(b) the name of the individual to whom the targeted substance was administered; and
(c) the name of the agent of the practitioner who administered the targeted substance.
- SOR/2010-223, s. 28.
- Date modified: